These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 25157835)

  • 1. Glomerular disease: innate immunity-APOL1 interaction.
    Sidaway P
    Nat Rev Nephrol; 2014 Oct; 10(10):543. PubMed ID: 25157835
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunity unmasks APOL1 in collapsing glomerulopathy.
    McNicholas BA; Nelson PJ
    Kidney Int; 2015 Feb; 87(2):270-2. PubMed ID: 25635718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1.
    Nichols B; Jog P; Lee JH; Blackler D; Wilmot M; D'Agati V; Markowitz G; Kopp JB; Alper SL; Pollak MR; Friedman DJ
    Kidney Int; 2015 Feb; 87(2):332-42. PubMed ID: 25100047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein L1-associated nephropathy and the future of renal diagnostics.
    Larsen CP; Freedman BI
    J Am Soc Nephrol; 2015 Jun; 26(6):1232-5. PubMed ID: 25573910
    [No Abstract]   [Full Text] [Related]  

  • 5. Genetics. Kidney disease is parasite-slaying protein's downside.
    Leslie M
    Science; 2010 Jul; 329(5989):263. PubMed ID: 20647431
    [No Abstract]   [Full Text] [Related]  

  • 6. Glomerular Effects of Age and APOL1.
    Meyer TW; Lenihan CR
    J Am Soc Nephrol; 2015 Dec; 26(12):2901-3. PubMed ID: 26038527
    [No Abstract]   [Full Text] [Related]  

  • 7. Editing of APOL1 mRNA reduces APOL1 expression and activation of innate immunity.
    Karttunen H; Ross MJ
    Kidney Int; 2023 Aug; 104(2):230-233. PubMed ID: 37224919
    [No Abstract]   [Full Text] [Related]  

  • 8. Familial focal segmental glomerulosclerosis (FSGS) in a Nigerian family and exclusion of mutations in NPHS2,WT1 and APOL1.
    Anochie IC; Eke FU; Okpere AN
    West Afr J Med; 2012; 31(4):273-6. PubMed ID: 23468032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Features and Histology of Apolipoprotein L1-Associated Nephropathy in the FSGS Clinical Trial.
    Kopp JB; Winkler CA; Zhao X; Radeva MK; Gassman JJ; D'Agati VD; Nast CC; Wei C; Reiser J; Guay-Woodford LM; Pollak MR; Hildebrandt F; Moxey-Mims M; Gipson DS; Trachtman H; Friedman AL; Kaskel FJ;
    J Am Soc Nephrol; 2015 Jun; 26(6):1443-8. PubMed ID: 25573908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice.
    Beckerman P; Bi-Karchin J; Park AS; Qiu C; Dummer PD; Soomro I; Boustany-Kari CM; Pullen SS; Miner JH; Hu CA; Rohacs T; Inoue K; Ishibe S; Saleem MA; Palmer MB; Cuervo AM; Kopp JB; Susztak K
    Nat Med; 2017 Apr; 23(4):429-438. PubMed ID: 28218918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APOL1 localization in normal kidney and nondiabetic kidney disease.
    Madhavan SM; O'Toole JF; Konieczkowski M; Ganesan S; Bruggeman LA; Sedor JR
    J Am Soc Nephrol; 2011 Nov; 22(11):2119-28. PubMed ID: 21997392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOL1 toxin, innate immunity, and kidney injury.
    Limou S; Dummer PD; Nelson GW; Kopp JB; Winkler CA
    Kidney Int; 2015 Jul; 88(1):28-34. PubMed ID: 25853332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APOL1 variants in HIV-associated nephropathy: just one piece of the puzzle.
    Hays T; Wyatt CM
    Kidney Int; 2012 Aug; 82(3):259-60. PubMed ID: 22791322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APOL1 Kidney Disease Risk Variants: An Evolving Landscape.
    Dummer PD; Limou S; Rosenberg AZ; Heymann J; Nelson G; Winkler CA; Kopp JB
    Semin Nephrol; 2015 May; 35(3):222-36. PubMed ID: 26215860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Custom Targeted Next-Generation Sequencing Gene Panel for the Diagnosis of Genetic Nephropathies.
    Larsen CP; Durfee T; Wilson JD; Beggs ML
    Am J Kidney Dis; 2016 Jun; 67(6):992-3. PubMed ID: 26795916
    [No Abstract]   [Full Text] [Related]  

  • 16. Most ApoL1 Is Secreted by the Liver.
    Shukha K; Mueller JL; Chung RT; Curry MP; Friedman DJ; Pollak MR; Berg AH
    J Am Soc Nephrol; 2017 Apr; 28(4):1079-1083. PubMed ID: 27932478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MYH9 and APOL1 are both associated with sickle cell disease nephropathy.
    Ashley-Koch AE; Okocha EC; Garrett ME; Soldano K; De Castro LM; Jonassaint JC; Orringer EP; Eckman JR; Telen MJ
    Br J Haematol; 2011 Nov; 155(3):386-94. PubMed ID: 21910715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Trypanosoma evansi infection linked to a lack of apolipoprotein L-I.
    Vanhollebeke B; Truc P; Poelvoorde P; Pays A; Joshi PP; Katti R; Jannin JG; Pays E
    N Engl J Med; 2006 Dec; 355(26):2752-6. PubMed ID: 17192540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APOL1 polymorphisms and development of CKD in an identical twin donor and recipient pair.
    Kofman T; Audard V; Narjoz C; Gribouval O; Matignon M; Leibler C; Desvaux D; Lang P; Grimbert P
    Am J Kidney Dis; 2014 May; 63(5):816-9. PubMed ID: 24518129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APOL1 nephropathy: from gene to mechanisms of kidney injury.
    Kruzel-Davila E; Wasser WG; Aviram S; Skorecki K
    Nephrol Dial Transplant; 2016 Mar; 31(3):349-58. PubMed ID: 25561578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.